1887

Abstract

Summary

Cytoplasmic RNA was prepared from biopsy material obtained from the nasopharynx of normal individuals and nasopharyngeal carcinoma (NPC) patients. Similar RNA preparations were prepared from lymphocytes of healthy donors and infectious mononucleosis patients. RNA was radioactively labelled and hybridized to cloned fragments of B95-8 Epstein-Barr virus (EBV). In all seropositive cases the minimum pattern of EBV-specific RNA expression was like that observed previously in latently infected, EBV-positive lymphoblastoid cell lines or Burkitt’s lymphoma biopsies. A novel observation was that all of the control biopsies from normal nasopharynxes expressed EBV-specific RNA, some of which appeared to be associated with a more active state of EBV infection. The pattern of expression in NPC patients was similar to that of the normal donors but showed some variations in complexity. In general the virus-specified small RNAs were not present in normal nasopharyngeal tissue but were expressed in the NPC biopsies.

Loading

Article metrics loading...

/content/journal/jgv/10.1099/0022-1317-68-4-1081
1987-04-01
2022-01-25
Loading full text...

Full text loading...

/deliver/fulltext/jgv/68/4/JV0680041081.html?itemId=/content/journal/jgv/10.1099/0022-1317-68-4-1081&mimeType=html&fmt=ahah

References

  1. Arrand J. R., Rymo L. 1982; Characterization OF the major Epstein-Barr virus-specific RNAs in Burkitt lymphoma-derived cells. Journal of Virology 41:376–389
    [Google Scholar]
  2. Arrand J. R., Rymo L., Walsh J. E., Bjorck E., Lindahl T., Griffin B. E. 1981; Molecular cloning of the complete Epstein-Barr virus genome as a set of overlapping restriction endonuclease fragments. Nucleic Acids Research 9:2999–3014
    [Google Scholar]
  3. Arrand J. R., Walsh-Arrand J. E., Rymo L. 1983; Cytoplasmic RNA from normal and malignant human cells shows homology to the DNAs of Epstein-Barr virus and human adenoviruses. EMBO Journal 2:1673–1683
    [Google Scholar]
  4. Bhat R. A., Thimmappaya B. 1985; Construction and analysis of additional adenovirus substitution mutants confirm the complementation of VA1 RNA function by two small RNAs encoded by Epstein-Barr virus. Journal of Virology 56:750–756
    [Google Scholar]
  5. Bornkamm G. W., Delius H., Zimber U., Hudewentz J., Epstein M. A. 1984; Comparison of Epstein-Barr virus strains of different origin by analysis of the viral DNAs. Journal of Virology 35:603–618
    [Google Scholar]
  6. Chen J-Y., Hwang L-Y., Beasley R. P., Chien C-S., Yang C-S. 1985; Antibody response to Epstein-Barr virus- specific DNase in 13 patients with nasopharyngeal carcinoma in Taiwan: a retrospective study. Journal of Medical Virology 16:99–105
    [Google Scholar]
  7. Chia W., Scott M. R. D., Rigby P. w. J. 1982; The construction of cosmid libraries of eukaryotic DNA using the Homer series of vectors. Nucleic Acids Research 10:2503–2520
    [Google Scholar]
  8. Dambaugh T., Nkrumah F. K., Biggar R. J., Kieff E. 1979; Epstein-Barr virus RNA in Burkitt tumor tissue. Cell 16:313–322
    [Google Scholar]
  9. Dambaugh T., Hennessy K., Chamnankit L., Kieff E. 1984; U2 region of Epstein-Barr virus DNA may encode Epstein-Barr nuclear antigen 2. Proceedings of the National Academy of Sciences U S A: 8176327636
    [Google Scholar]
  10. De The G., Geser A., Day N. E., Tukei P. M., Williams E. H., Beri D. P., Smith P. G., Dean A. G., Bornkamm G. W., Feorino P., Henle W. 1978; Epidemiological evidence for causal relationship between Epstein-Barr virus and Burkitt’s lymphoma: results of the Ugandan prospective study. Nature; London: 274756–761
    [Google Scholar]
  11. Dillner J., Kallin B., Ehlin-Henriksson B., Timar L., Klein G. 1985a; Characterization of a second Epstein-Barr virus-determined nuclear antigen associated with theBamHlWYH region of EBV DNA. International Journal of Cancer 35:359–366
    [Google Scholar]
  12. Dillner J., Kallin B., Klein G., Iornvall H., Alexander H., Lerner R. 1985b; Antibodies against synthetic peptides react with the second Epstein-Barr virus-associated nuclear antigen. EMBO Journal 4:1813–1818
    [Google Scholar]
  13. Dolyniuk M., Wolff E., Kieff E. 1976; Proteins of Epstein-Barr virus. II. Electrophoretic analysis of the polypeptides of the nucleocapsid and the glucosamine- and polysaccharide-containing components of enveloped virus. Journal of Virology 18:289–297
    [Google Scholar]
  14. Favaloro J., Treisman R., Kamen R. 1980; Transcription maps of polyoma virus-specific RNA: analysis by 2D nuclease mapping. Methods in Enzymology 65:718–749
    [Google Scholar]
  15. Fennewald S., Van Santen V., Kieff E. 1984; Nucleotide sequence of an mRNA transcribed in latent, growthtransforming virus infection indicates that it may encode a membrane protein. Journal of Virology 51:411–419
    [Google Scholar]
  16. Glaser R., De The G., Lenoir G., Ho J. H. C. 1976; Superinfection of nasopharyngeal carcinoma epithelial tumor cells with Epstein-Barr virus. Proceedings of the National Academy of Sciences U.S.A: 73960–963
    [Google Scholar]
  17. Griffin B. E., Karran L. 1984; Immortalisation of monkey epithelial cells by specific fragments of Epstein- Barr virus DNA. Nature; London: 30978–82
    [Google Scholar]
  18. Hanto D. W., Frizzera G., Gajl-Peczlska K. I., Sakamoto K., Purtilo D. T., Balfour H. H.Jr. Simmons R. L., Najarian J. S. 1982; Epstein-Barr virus-induced B-cell lymphoma after renal transplantation. Acyclovir therapy and transition from polyclonal to monoclonal B-cell proliferation. New England Journal of Medicine 306:913–918
    [Google Scholar]
  19. Henle G., Henle W. 1966; Immunofluorescence in cells derived from Burkitt’s lymphoma. Journal of Bacteriology 91:1248–1256
    [Google Scholar]
  20. Henle G., Henle W. 1976; Epstein-Barr virus-specific IgA serum antibodies as an outstanding feature of nasopharyngeal carcinoma. International Journal of Cancer 17:1–7
    [Google Scholar]
  21. Henle G., Henle W., Diehl V. 1968; Relation of Burkitt tumor associated herpes-type virus to infectious mononucleosis. Proceedings of the National Academy of Sciences U.S.A: 5994–101
    [Google Scholar]
  22. Henle G., Henle W., Clifford P., Diehl V., Kafuko G. W., Kirya B. G., Klein G., Morrow R. H., Munube G. M. R., Pike M. C., Tukei P. M., Ziegler J. G. 1969; Antibodies to EB virus in Burkitt’s lymphoma and control groups. Journal of the National Cancer Institute 43:1147–1457
    [Google Scholar]
  23. Hennessy K., Fennewald S., Hummel M., Cole T., Kieff E. 1984; A membrane protein encoded by Epstein- Barr virus in latent growth-transforming infection. Proceedings of the National Academy of Sciences U.S.A: 817207–7211
    [Google Scholar]
  24. Hudson G. S., Farrell P., Barrell B. G. 1985; Two related but differentially expressed potential membrane proteins encoded by the EcoRI Dhet region of Epstein-Barr virus B95-8. Journal of Virology 53:528–535
    [Google Scholar]
  25. Hummel M., Kieff E. 1982a; Epstein-Barr virus RNA. VIII. Viral RNA in permissively infected B95-8 cells. Journal of Virology 43:262–272
    [Google Scholar]
  26. Hummel M., Kieff E. 1982b; Mapping of polypeptides encoded by the Epstein-Barr virus genome in productive infection. Proceedings of the National Academy of Sciences U.S.A: 795698–5702
    [Google Scholar]
  27. Jat P., Arand J. R. 1982; In vitrotranscription of two Epstein-Barr virus specified small RNA molecules. Nucleic Acids Research 10:3407–3425
    [Google Scholar]
  28. Johnson D. A., Gautsch J. W., Sportsman J. R., Elder J. H. 1984; Improved technique utilizing non-fat dry milk for analysis of proteins and nucleic acids transferred to nitrocellulose. Gene Analytical Techniques 1:3–8
    [Google Scholar]
  29. Kaplan M. E., Clark C. 1974; An improved rosetting assay for detection of human T lymphocytes. Journal of Immunological Methods 5:131–135
    [Google Scholar]
  30. King W., Thomas-Powell A. L., Raab-Traub N., Hawke M., Kieff E. 1980; Epstein-Barr virus RNA. V. Viral RNA in a restringently infected, growth transformed cell-line. Journal of Virology 36:506–518
    [Google Scholar]
  31. Klein G., Clifford P., Klein E., Stjernsward J. 1966; Search for tumor-specific immune reactions in Burkitt lymphoma patients by the membrane immunofluorescence reaction. Proceedings of the National Academy of Sciences U.S.A: 551628–1635
    [Google Scholar]
  32. Kreig P., Amtmann E., Sauer G. 1983; The simultaneous extraction of high molecular weight DNA and of RNA from solid tumors. Analytical Biochemistry 134:288–294
    [Google Scholar]
  33. Lemon S. M., Hutt L. M., Shaw J. E., Li J-L.H. 1977; Replication of EBV in epithelial cells during infectious mononucleosis. Nature; London: 268268–270
    [Google Scholar]
  34. Mann K. P., Staunton D., Thorley-Lawson D. A. 1985; Epstein-Barr virus encoded protein found in plasma membranes of transformed cells. Journal of Virology 55:710–720
    [Google Scholar]
  35. Miller G. 1984; Regions of the EBV genome involved in latency and lymphocyte immortalization. Progress in Medical Virology 30:107–128
    [Google Scholar]
  36. Mueller-Lantzsch N., Lenoir G. M., Sauter M., Takaki K., Bechet J-M., Kuklik-Roos C., Wunderlich D., Bornkamm G. W. 1985; Identification of the coding region for a second Epstein-Barr virus nuclear antigen (EBNA 2) by transfection of cloned DNA fragments. EMBO Journal 4:1805–1811
    [Google Scholar]
  37. Murthy S., Kamine J., Desrosiers R. C. 1986; Viral-encoded small RNAs in herpes virus saimiri induced tumors. EMBO Journal 5:1625–1632
    [Google Scholar]
  38. Raab-Traub N., Hood R., Young C-S., Henry B.III Pagano J. S. 1983; Epstein-Barr virus transcription in nasopharyngeal carcinoma. Journal of Virology 48:580–590
    [Google Scholar]
  39. Reichel P. A., Merrick W. C., Siekierka J. 1984; Regulation of a protein synthesis initiation factor by adenovirus virus associated RNA I. Nature; London: 313196–200
    [Google Scholar]
  40. Rosa M. D., Gottlieb E., Lerner M. R., Steitz I. A. 1981; Striking similarities are exhibited by two small Epstein-Barr virus-encoded RNAs and the adenovirus-associated RNAs VAI and VAII. Molecular and Cellular Biology 1:785–796
    [Google Scholar]
  41. Rymo L. 1979; Identification of transcribed regions of Epstein-Barr virus DNA in Burkitt lymphoma derived cells. Journal of Virology 32:8–18
    [Google Scholar]
  42. Rymo L., Klein G., Ricksten A. 1985; Expression of a second Epstein-Barr virus-determined nuclear antigen in mouse cells after gene transfer with a cloned fragment of the viral genome. Proceedings of the National Academy of Sciences U.S.A: 823435–3439
    [Google Scholar]
  43. Seibl R., Wolf H. 1985; Mapping of Epstein-Barr virus proteins on the genome by translation of hybrid- selected RNA from induced P3HR-1 cells and induced Raji cells. Virology 141:1–13
    [Google Scholar]
  44. Shanmugaratnam K., Sabin L. 1978; Histological typing of upper respiratory tract tumours. International Histological Typing of Tumours 19 p. 32 Geneva: WHO;
    [Google Scholar]
  45. Siekierka L., Mariano T. M., Reichel P. A., Mathews M. B. 1985; Translational control by adenovirus: lack of virus-associated RNA I during adenovirus infection results in phosphorylation of initiation factor eIF-2 and inhibition of protein synthesis. Proceedings of the National Academy of Sciences U.S.A: 821959–1963
    [Google Scholar]
  46. Simons M. I., Shanmugaratnam K.editor 1982 The Biology of Nasopharyngeal Carcino Technical Report Series 71 Geneva: UICC;
    [Google Scholar]
  47. Summers W. P., Grogan E. A., Shedd D., Roberts M., Liv C-R., Miller G. 1982; Stable expression in mouse cells of nuclear neoantigen following transfer of a 3-4 megadalton cloned fragment of Epstein-Barr virus DNA. Proceedings of the National Academy of Sciences U.S.A: 795688–5692
    [Google Scholar]
  48. Thimmappaya B., Weinberger C., Schneider R. C., Shenk T. 1982; Adenovirus VAI RNA is required for efficient translation of viral mRNAs at late times after infection. Cell 31:543–551
    [Google Scholar]
  49. Thomas J. A., Iliescu V., Crawford D. H., Ellouz R., Cammoun M., De The G. 1984; Expression of HLA-DR antigens in nasopharyngeal carcinoma: an immunohistological analysis of the tumour cells and infiltrating lymphocytes. International Journal of Cancer 33:813–819
    [Google Scholar]
  50. Thomas-Powell A. L., King W., Kieff E. 1979; Epstein-Barr virus-specific RNA. III. Mapping of DNA encoding viral RNA in restringent infection. Journal of Virology 29:261–274
    [Google Scholar]
  51. Trumper P. A., Epstein M. A., Giovanella B. C. 1976; Activationin vitroby BUdR of a productive EB virus infection in the epithelial cells of nasopharyngeal carcinoma. International Journal of Cancer 17:578–587
    [Google Scholar]
  52. Van Santen V., Cheung A., Kieff E. 1981; Epstein-Barr virus RNA. VII. Size and direction of virus-specified cytoplasmic RNAs in a transformed cell-line. Proceedings of the National Academy of Sciences U.S.A: 781930–1934
    [Google Scholar]
  53. Van Santen V., Cheung A., Hummel M., Kieff E. 1983; RNA encoded by the IRI-U2 region of Epstein-Barr virus DNA in latently-infected, growth-transformed cells. Journal of Virology 46:424–433
    [Google Scholar]
  54. Weigel R., Miller G. 1983; Major EB virus-specific cytoplasmic transcripts in a cellular clone of the HR-1 Burkitt lymphoma line during latency and after induction of viral replicative cycle by phorbol esters. Virology 125:287–298
    [Google Scholar]
  55. Wolf H., Zur Hausen H., Becker V. 1973; Epstein-Barr virus genomes in epithelial nasopharyngeal carcinoma cells. Nature; London: 244245–246
    [Google Scholar]
  56. Yao Q. Y., Rickinson A. B., Epstein M. A. 1985; A re-examination of the Epstein-Barr virus carrier state in healthy seropositive individuals. International Journal of Cancer 35:35–42
    [Google Scholar]
  57. Zeng Y., Zhang L. G., Li H. Y., Jan M. G., Zhang Q., Wu Y. C., Wang Y. S., Su G. R. 1982; Serological mass survey for early detection of nasopharyngeal carcinoma in Wuzhou City, China. International Journal of Cancer 19:139–141
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jgv/10.1099/0022-1317-68-4-1081
Loading
/content/journal/jgv/10.1099/0022-1317-68-4-1081
Loading

Data & Media loading...

Most cited this month Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error